Biogen Stock: Is BIIB Underperforming the Healthcare Sector?
Biogen has recently lagged behind the broader healthcare sector, and analysts maintain a cautiously optimistic outlook on the stock’s long-term growth potential.
Symbol | Last Price | Change | % Change |
---|---|---|---|